Report Detail
Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals
- RnM2839521 |
- 30 January, 2019 |
- Global |
- 79 Pages |
- GlobalData |
- Pharma & Healthcare
Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals
Summary
GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in October 2018. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of Contents
1 Table of Contents 2
- 1.1 List of Tables 5
- 1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 10
- 2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, October 2018 10
- 2.2 Pharmaceuticals & Healthcare, Global, Major Deals, October 2018 12
- 2.2.1 AstraZeneca Enters into Co-development Agreement with Innate Pharma 12
- 2.2.2 Novartis to Acquire Endocyte 12
- 2.2.3 Janssen Pharma Enters into Research and Option Agreement with Arrowhead Pharma 13
- 2.2.4 Grunenthal Receives Rights for Nexium from AstraZeneca 13
- 2.2.5 Dragonfly Therapeutics Enters into Collaboration Agreement with Merck 14
- 2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, October 2018 15
- 2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, October 2018 16
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 17
- 3.1 Pharmaceuticals & Healthcare, Global, M&A, October 2018 17
- 3.1.1 Top M&A Deals in October 2018 18
- 3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, May 2018 - October 2018 19
- 3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, October 2018 20
- 3.2.1 Top Equity Offering Deals in October 2018 21
- 3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, May 2018 - October 2018 22
- 3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, October 2018 23
- 3.3.1 Top PE/VC Deals in October 2018 24
- 3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, October 2018 25
- 3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, October 2018 26
- 3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2016-October 2018 28
- 3.3.7 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2016-October 2018 29
- 3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, October 2018 30
- 3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, May 2018 - October 2018 31
- 3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), October 2018 32
- 3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, October 2018 33
- 3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), May 2018 - October 2018 34
- 3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, May 2018 - October 2018 35
- 3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), May 2018 - October 2018 36
- 3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), May 2018 - October 2018 37
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, October 2018 38
- 4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, October 2018 38
- 4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), October 2018 39
- 4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), May 2018 - October 2018 40
- 4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), May 2018 - October 2018 41
- 4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), May 2018 - October 2018 42
- 4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), May 2018 - October 2018 44
- 4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, October 2018 45
- 4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, October 2018 45
- 4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, October 2018 46
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 47
- 5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, October 2018 47
- 5.1.1 Oncology - Deals of the Month 48
- 5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, October 2018 49
- 5.2.1 Central Nervous System - Deals of the Month 50
- 5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, October 2018 52
- 5.3.1 Infectious Diseases - Deals of the Month 53
- 5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, October 2018 55
- 5.4.1 Cardiovascular - Deals of the Month 56
- 5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, October 2018 58
- 5.5.1 Immunology - Deal of the Month 59
- 5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, October 2018 60
- 5.6.1 Gastrointestinal - Deals of the Month 61
- 5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, October 2018 62
- 5.7.1 Metabolic Disorders - Deals of the Month 63
6 Deal Summary by Geography 64
- 6.1 Pharmaceuticals & Healthcare, North America Deals, October 2018 64
- 6.1.1 North America - Deals of the Month 65
- 6.2 Pharmaceuticals & Healthcare, Europe, Deals, October 2018 67
- 6.2.1 Europe - Deals of the Month 68
- 6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, October 2018 70
- 6.3.1 Asia-Pacific - Deals of the Month 71
- 6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, October 2018 72
- 6.4.1 Rest of the World - Deals of the Month 73
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 75
- 7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, May 2018 - October 2018 75
- 7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, May 2018 - October 2018 76
8 Further Information 77
- 8.1 Methodology 77
- 8.2 About GlobalData 78
- 8.3 Contact Us 78
- 8.4 Disclosure information 78
Summary:
Get latest Market Research Reports on Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals. Industry analysis & Market Report on Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals is a syndicated market report, published as Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals. It is complete Research Study and Industry Analysis of Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
